Not recommended for herpes simplex virus (HSV) testing; IgM lacks adequate predictive value for acute infection. If pursuing antibody testing, preferred test is Herpes Simplex Type 1 and Type 2 Glycoprotein G-Specific Antibodies, IgG by CIA (0051152). If acute HSV infection is suspected, molecular testing is preferred (refer to Herpes Simplex Virus by PCR (0060041)).
Semi-Quantitative Enzyme-Linked Immunosorbent Assay/Semi-Quantitative Chemiluminescent Immunoassay
Serum separator tube.
Transfer 1 mL serum to an ARUP Standard Transport Tube. (Min: 0.5 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens. Mark specimens plainly as "acute" or "convalescent."
Refer to individual components.
After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles)
|0050293||Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgG||
|0050641||Herpes Simplex Virus Type 1 and/or 2 Antibodies, IgM by ELISA||
No compliance statements are in use for this test.
|Component Test Code*||Component Chart Name||LOINC|
|0050286||HSV Type 1/2 Combined Ab, IgG||27948-9|
|0050641||HSV 1 and/or 2 Abs, IgM by ELISA||41399-7|
- HSV 1 and 2
- HSV 1 and 2 antibody panel
- HSV 1, 2
- HSV 1, 2, IgG IgM